Tarsus director acquires 2,954 shares via RSU vesting
Tarsus Pharmaceuticals director Wendy L. Yarno acquired 2,954 shares of common stock through the settlement of vested Restricted Stock Units (RSUs).
Rhea-AI Filing Summary
Tarsus Pharmaceuticals director Wendy L. Yarno acquired 2,954 shares of common stock through the settlement of vested Restricted Stock Units (RSUs). Each RSU converted into one share of common stock, reflecting compensation for her service as a non-employee director. The RSUs were granted on June 12, 2025 and vested in full on the one-year anniversary of the grant date, subject to continuous service. Following this RSU settlement, Yarno directly holds 16,654 shares of Tarsus Pharmaceuticals common stock, and the RSU balance from this grant is now fully settled.
Positive
- None.
Negative
- None.
Insider Trade Summary
2,954 shares exercised/converted
Exercise
2 txns
Insider
YARNO WENDY L
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 2,954 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,954 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 0 contracts (Direct);
Common Stock — 16,654 shares (Direct)
Footnotes (3)
- F1. The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
- F2. Each RSU represents a contingent right to receive one share of the Company's common stock.
- F3. RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
Key Figures
RSUs settled: 2,954 shares
Shares held after transaction: 16,654 shares
RSU-to-share ratio: 1 RSU : 1 share
+2 more
5 metrics
RSUs settled
2,954 shares
Vested RSUs converted to common stock on June 12, 2026
Shares held after transaction
16,654 shares
Director Wendy L. Yarno direct Tarsus common stock holdings post-settlement
RSU-to-share ratio
1 RSU : 1 share
Each Restricted Stock Unit represents one Tarsus common share
Exercise price per RSU
$0.00 per unit
RSUs settled into shares at no cash exercise price
Exercise transactions
1 exercise, 2,954 shares
Form 4 transaction summary exerciseCount and exerciseShares
Key Terms
Restricted Stock Units, contingent right, non-employee director, derivative exercise/conversion, +1 more
5 terms
Restricted Stock Units financial
"The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs")."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each RSU represents a contingent right to receive one share of the Company's common stock."
non-employee director financial
"RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director"
derivative exercise/conversion financial
"transaction_action: derivative exercise/conversion"
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Tarsus (TARS) director Wendy L. Yarno report?
Wendy L. Yarno reported acquiring 2,954 Tarsus common shares through settlement of vested RSUs. These Restricted Stock Units converted into shares as part of her non-employee director compensation for service tied to the company’s 2025 annual stockholder meeting.
Was Wendy L. Yarno’s Tarsus (TARS) transaction an open-market buy or sale?
The transaction was not an open-market buy or sale. It reflects the exercise and settlement of 2,954 vested Restricted Stock Units into common shares, a compensation-related event tied to her service as a non-employee director of Tarsus Pharmaceuticals.
What are the terms of the Tarsus (TARS) RSUs reported by Wendy L. Yarno?
The RSUs were granted on June 12, 2025 in connection with Wendy L. Yarno’s service as a non-employee director. They vest in full on the one-year anniversary of the grant date, contingent on her continuous service on Tarsus’s board.
AI-generated analysis. How Rhea-AI works. Not financial advice.
